Performance characteristics of a new Immulite® 2000 system erythropoietin assay

William E. Owen, William L. Roberts

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Background: Serum erythropoietin (EPO) measurements are useful for diagnostic evaluations of anemia, polycythemia, and other erythroid disorders. Methods: We evaluated a new formulation of the chemiluminescent immunoassay for EPO on the Immulite 2000 analyzer (Siemens Healthcare Diagnostics) for limit of blank (LoB), imprecision, linearity, interference, comparison to another commercially available assay, reference interval, and cross-reactivity with 2 recombinant EPO preparations. Results: The LoB was 0.23IU/l. Total imprecision ranged from 4.2 to 12.1%. The assay was linear from 0 to 678IU/l. Hemoglobin caused negative interference at concentrations >17.4g/l. Deming regression from the method comparison study gave a slope of 1.00±0.04, an intercept of 3.9±12.7, and a Sy/x of 44.9 (r=0.98). The non-parametric reference interval was 3.3 to 23.4IU/l. Epoetin alfa at a1:2000 dilution gave mean results of 541IU/l and 650IU/l for Immulite 2000 and Access 2, respectively. Darbopoetin alfa at a 1:2000 dilution gave mean results of 337IU/l and 579IU/l for the Immulite 2000 and Access 2, respectively, indicating the 2 assays have substantially different cross-reactivities with recombinant EPO preparations. Conclusions: The new Immulite 2000 EPO assay shows acceptable performance and is suitable for routine clinical use. © 2010 Elsevier B.V.
Original languageEnglish (US)
Pages (from-to)480-482
Number of pages3
JournalClinica Chimica Acta
Issue number5-6
StatePublished - Feb 20 2011
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Performance characteristics of a new Immulite® 2000 system erythropoietin assay'. Together they form a unique fingerprint.

Cite this